Gemin X Pharmaceuticals, Inc. to Present at the 7th Annual Biotechnology Industry Organization (BIO) Investor Forum

MALVERN, Pa. & MONTREAL--(BUSINESS WIRE)--Gemin X, a clinical stage biopharmaceutical company developing novel, targeted cancer therapeutics, today announced that Glenn Gormley, M.D., Ph.D., president and chief executive officer of Gemin X, is scheduled to present at The 7th Annual BIO Investor Forum, being held October 29-31, 2008 at the Palace Hotel in San Francisco. Dr. Gormley’s presentation will take place on Wednesday, October 29, 2008 at 4:15 p.m. PDT.